Estados Unidos · Agencias y tiempo real · Business Wire

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Publicado por Business Wire · Estados Unidos hace 14 h

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its ...

Leer el artículo completo en Business Wire Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.businesswire.com)

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

También te puede interesar

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Compartir

También te puede interesar

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening